Roche Diagnostics Announces Dan Zabrowski as New Head of Roche Applied Science
As of February 1, 2012, Dan Zabrowski is Head of Roche Applied Science in the Diagnostics Division, located in Penzberg, Germany. He succeeds Paul Brown who has led Roche Applied Science since September 2011. Dan Zabrowski will report to Daniel O’Day, COO Roche Diagnostics.
Dan recently served as Global Head of Roche Partnering and was a member of the Roche Corporate Executive Committee and Chugai Board. He joined Roche in 1994 through the acquisition of Syntex. During his career at Roche, Dan held a number of management positions in Regulatory Affairs and Development. Dan holds a Ph.D. in Organic Chemistry from the University of Indiana.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
BASF’s Nutrition & Health division to focus on growth and increased competitiveness - Reduction of about 260 positions worldwide by end of 2015
Fisher Biosciences unit, Cellomics, and Evotec Technologies Sign License Agreement - Companies to collaborate on cell-biology solutions for life-science markets
Arthur_Peacocke
University of Konstanz and Johns Hopkins Bloomberg School of Public Health Establish Center of Alternatives to Animal Testing
CyBio and LiCONiC Instruments Announce a Distribution Partnership

The dark matter of the brain - Omnipresent and yet hardly explored: Electrical synapses
New biomarker links cancer progression to genome instability - High level of specific protein in tumors indicates prognosis
KUROS announces allowance of European Patent for synthetic biomaterials
Agilent Technologies and Agendia Sign Agreement on Molecular Cancer Diagnostics
Category:Lyases
